购物车里没有产品

Anti-NFkB p105/p50 antibody

产品货号 产品 品牌 单位 存货 价格 促销价 数量  
AB-06-3126
Anti-NFkB p105/p50 antibody
洱畔/Erpan Tech 有货

产品特性        

Product Cat#: AB-06-3126
Product type: Primary antibody
Antigen: NFkB p105/p50
Immunogen: Recombinant protein
Species immunized: Mouse
Isotype: IgG
Applications: Western Blot (1:200-1:4000); Immunohistochemistry (1:100-1:200)
Reactivity: Mouse, Rat and Human
Clonality (clone number): Monoclonal(SZ20-01)
Form: Liquid
Buffer: 1*TBS (pH7.4), 1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1 mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: DKFZp686C01211 antibody
DNA binding factor KBF1 antibody
DNA binding factor KBF1 EBP1 antibody
DNA-binding factor KBF1 antibody
EBP 1 antibody
EBP-1 antibody
EBP1 antibody
KBF1 antibody
MGC54151 antibody
NF kappa B antibody
NF kappaB antibody
NF kappabeta antibody
NF kB1 antibody
NFkappaB antibody
NFKB 1 antibody
NFKB p105 antibody
NFKB p50 antibody
Nfkb1 antibody
NFKB1_HUMAN antibody
Nuclear factor kappa B DNA binding subunit antibody
Nuclear factor kappa-B, subunit 1 antibody
Nuclear factor NF kappa B p105 subunit antibody
Nuclear factor NF kappa B p50 subunit antibody
Nuclear factor NF-kappa-B p50 subunit antibody
Nuclear factor of kappa light chain gene enhancer in B cells 1 antibody
Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 antibody
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 antibody
p105 antibody
p50 antibody
展开

靶标信息

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5′-GGRNNYYCC-3′, located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

产品来源

洱畔科技实验室

文件下载

MSDS-AB-06-3126.pdf (下载65)